Erianin Suppresses Pancreatic Cancer Progression by Inducing Cell Cycle Arrest and Ferroptosis
Cancer Management and Research · 2025-08 · Volume 17 · 1657-1666
DOI: 10.2147/cmar.s540437 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Management and Research, 2025-08. Verfasst von Xiao Qu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Zhangjiagang Hospital Affiliated to Soochow University, Zhangjiagang, People's Republic of China. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, Zhangjiagang Hospital Affiliated to Soochow University, Zhangjiagang, People's Republic of China.
- Zhangjiagang Hospital Affiliated to Soochow University, Zhangjiagang, People's Republic of China.
- Department of Gastroenterology, Zhangjiagang Hospital of Traditional Chinese Medicine, Zhangjiagang, People's Republic of China.
Zitieren
APA
Qu, X., He, B., Zhang, Y., Hang, L., & Lu, P. (2025). Erianin Suppresses Pancreatic Cancer Progression by Inducing Cell Cycle Arrest and Ferroptosis. Cancer Management and Research, Volume 17, 1657-1666. https://doi.org/10.2147/cmar.s540437
Vancouver
Qu X, He B, Zhang Y, Hang L, Lu P. Erianin Suppresses Pancreatic Cancer Progression by Inducing Cell Cycle Arrest and Ferroptosis. Cancer Management and Research. 2025;Volume 17:1657-1666. doi:10.2147/cmar.s540437
BibTeX
@article{Qu2025,
author = {Qu, Xiao and He, Bin and Zhang, Yaohui and Hang, Li and Lu, Ping},
title = {Erianin Suppresses Pancreatic Cancer Progression by Inducing Cell Cycle Arrest and Ferroptosis},
journal = {Cancer Management and Research},
year = {2025},
volume = {Volume 17},
pages = {1657--1666},
doi = {10.2147/cmar.s540437}
}
EUVIMED